APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer's Disease Risk in a Multiracial Sample
Choi, KY, Lee, JJ, Gunasekaran, TI, Kang, S, Lee, W, Jeong, J, Lim, HJ, Zhang, X, Zhu, C, Won, SY, Choi, YY, Seo, EH, Lee, SC, Gim, J, Chung, JY, Chong, A, Byun, MS, Seo, S, Ko, PW, Han, JW, McLean, C, Farrell, J, Lunetta, KL, Miyashita, A, Hara, N, Won, S, Choi, SM, Ha, JM, Jeong, JH, Kuwano, R, Song, MK, An, SSA, Lee, YM, Park, KW, Lee, HW, Choi, SH, Rhee, S, Song, WK, Lee, JS, Mayeux, R, Haines, JL, Pericak-Vance, MA, Choo, ILH, Nho, K, Kim, KW, Lee, DY, Kim, S, Kim, BC, Kim, H, Jun, GR, Schellenberg, GD, Ikeuchi, T, Farrer, LA, Lee, KH and Neuroimaging Initative, AD
2019; vol. 7;
Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts
St John-Williams, L, Mahmoudiandehkordi, S, Arnold, M, Massaro, T, Blach, C, Kastenmuller, G, Louie, G, Kueider-Paisley, A, Han, X, Baillie, R, Motsinger-Reif, AA, Rotroff, D, Nho, K, Saykin, AJ, Risacher, SL, Koal, T, Moseley, MA, Tenenbaum, JD, Thompson, JW and Kaddurah-Daouk, R
2019; Journal Sci Data; vol. 6; no. 1; pp. 212;